Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: ivp dye, iodine containing attending: chief complaint: common bile duct injury major surgical or invasive procedure: exploratory laparotomy roux-en-y hepaticojejunostomy. history of present illness: 80-year-old female who underwent an open cholecystectomy that was complicated by development of a complete transection of the common bile duct. at the time, the injury was recognized intraoperatively and the distal bile duct was tied off as well as the proximal bile duct and a t tube was placed in the proximal portion of the biliary tree in communication with the liver. the patient was allowed to recover from this surgery and was in the process of being referred for definitive evaluation when she presented with a malpositioned t tube and abdominal pain. she was sent to our facility for further evaluation. she underwent complete work-up including placement of a percutaneous transhepatic cholangiogram in the distal bile duct and now presents for definitive repair. past medical history: dm ii htn hypercholesterolemia obesity social history: retired bank teller. lives alone in falmoth, daughter lives in . denies tobacco and etoh use. family history: non-contributory physical exam: on discharge nad, a&0x3 rrr ctab soft, nt/nd wound- c/d/i t-tube in place no le edema pertinent results: 12:10am blood wbc-14.2* rbc-3.62* hgb-10.2* hct-30.8* mcv-85 mch-28.3 mchc-33.2 rdw-15.1 plt ct-253 05:50am blood wbc-13.9* rbc-3.57* hgb-10.2* hct-30.4* mcv-85 mch-28.5 mchc-33.4 rdw-15.2 plt ct-248 06:00am blood wbc-6.1 rbc-3.17* hgb-8.9* hct-26.8* mcv-85 mch-28.0 mchc-33.1 rdw-15.4 plt ct-302 05:00am blood wbc-6.0 rbc-3.27* hgb-9.1* hct-27.2* mcv-83 mch-27.9 mchc-33.5 rdw-15.4 plt ct-308 12:10am blood pt-16.8* ptt-27.3 inr(pt)-1.5* 12:10am blood plt ct-253 05:50am blood plt ct-248 09:05am blood pt-17.4* ptt-28.3 inr(pt)-1.6* 05:00am blood pt-13.3* ptt-27.2 inr(pt)-1.2* 06:00am blood plt ct-302 05:00am blood plt ct-308 12:10am blood glucose-254* urean-17 creat-1.4* na-139 k-4.3 cl-108 hco3-19* angap-16 05:50am blood glucose-259* urean-17 creat-1.4* na-135 k-4.1 cl-102 hco3-19* angap-18 06:00am blood glucose-98 urean-14 creat-1.2* na-141 k-3.9 cl-105 hco3-25 angap-15 05:00am blood glucose-102 urean-13 creat-1.1 na-139 k-3.3 cl-102 hco3-28 angap-12 12:10am blood alt-235* ast-237* alkphos-401* amylase-36 totbili-3.2* 05:50am blood alt-209* ast-193* alkphos-383* amylase-31 totbili-3.4* 07:35am blood alt-121* ast-66* alkphos-276* totbili-1.6* 10:23am blood alt-78* ast-30 alkphos-260* amylase-28 totbili-1.0 05:45am blood alt-53* ast-25 ld(ldh)-177 alkphos-250* amylase-33 totbili-0.8 05:35am blood alt-42* ast-34 alkphos-291* amylase-44 totbili-0.7 05:05am blood alt-37 ast-44* alkphos-385* totbili-0.8 05:15am blood alt-23 ast-22 alkphos-134* amylase-17 totbili-0.6 05:00am blood alt-17 ast-19 alkphos-178* amylase-19 totbili-0.6 06:00am blood alt-16 ast-23 alkphos-205* amylase-22 totbili-0.6 05:00am blood alt-20 ast-29 alkphos-251* amylase-24 totbili-0.5 12:10am blood lipase-47 05:50am blood lipase-35 10:23am blood lipase-38 05:00am blood lipase-20 06:00am blood lipase-23 05:00am blood lipase-32 12:10am blood albumin-3.3* calcium-8.9 phos-3.1 mg-1.3* 05:50am blood albumin-3.2* calcium-8.5 phos-2.9 mg-1.2* 07:35am blood albumin-2.8* 05:00am blood calcium-8.2* phos-3.0 mg-1.4* 06:00am blood albumin-2.5* calcium-8.2* phos-3.7 mg-1.5* 05:00am blood calcium-8.3* phos-3.5 mg-1.6 brief hospital course: pt was admitted to surgical service for management of cbd injury. percutaneous transhepatic cholangiogram demonstrated dilated intrahepatic biliary duct and obstructed common hepatic duct with contrast extravasation into a contained collection. no opacification of common bile duct. an 8 french external drainage catheter was placed and connected with a bag. she was started on vanco, levo and flagyl. blood cultures on admission grew pan-sensitive enterococcus faecalis. she received iv levaquin and po linezolid. a cardiac echo was done that did not demonstrated vegetations. pt was managed conservatively until operation. she remained in the hospital until surgery. cardiology was consultation for preop eval. a p-mibi stress test was done. recommendations included improved bp control for which lopresor was increased and norvasc was started. asa was recommended as well as reinstituting zocor. ct a/p 1. interval improvement in intrahepatic biliary dilatation, status post catheter placement. 2. significant improvement in perihepatic inflammatory process centered in the hepatic flexure region. 3. imaging findings are at least concerning for transection of common bile duct. . p mibi: normal myocardial perfusion. normal left ventricular cavity size and systolic function. . echo: 1. the left atrium is mildly dilated. 2. left ventricular wall thickness, cavity size, and systolic function are normal (lvef>55%). regional left ventricular wall motion is normal. 3. the aortic valve leaflets (3) are mildly thickened. 4. the mitral valve leaflets are mildly thickened. trivial mitral regurgitation is seen. . pre-op cxr: moderate enlargement of the cardiac silhouette is slightly more severe consistent with mild cardiomegaly and/or pericardial effusion. there is no pulmonary edema or congestion of vessels in the lung or mediastinum to indicate clinically significant cardiac decompensation. new linear opacities in the left lower lung are due to atelectasis. lungs are otherwise clear. there is no pleural effusion or evidence of central adenopathy. thoracic aorta particularly at the arch, shows calcification but no dilatation. . on she was taken to the or by dr. for exploratory laparotomy, roux-en-y hepaticojejunostomy. she was in satisfactory condition and was kept in the pacu for low uop. pt was moved to the floor and low uop continued. pt was moved to the sicu for closer hemodynamic monitoring (eg cvp) for post-op hypovolemia. pt was awake and oriented throughout. pt was transfused one unit prbc. pt responded to fluid boluses and uop improved. pod 3 pt was moved back to the medical-surgical unit. diet was started, and supplements added. she complained on persistent nausea, no appetite and vomiting after eating. metformin, actos and glyburide were held for possibility etiology of nausea, vomiting and fluid retention. insulin sliding scale was used and consult was obtained. an egd was performed that demonstrated gastritis. zantac was d/c'd and protonix was increased to and maalox was administered with improvement in appetite and dietary tolerance. actos and glyburide were restarted pod 5 pt had cholangiogram: contrast in the common hepatic duct, right and left hepatic ducts and multiple intrahepatic divisions as well as contrast in the jejunum. no obstruction or stricture identified. no extraluminal contrast. an abdominal ct was done on that demonstrated the following: stable appearance of the perihepatic inflammatory process, involving the surgical bed, hepatic flexure, and omentum. no organized abscess/fluid collection. 2) interval decrease in size in the small fluid collection adjacent to the pancreatic tail. 3) no evidence of bowel obstruction. 4) right adrenal adenoma. 5) probable tiny left lower lobe pulmonary nodule. she required increased lopressor, hctz and ntg tp for bp control for sbp's in range of 170/80-160/70. bp decreased on these meds to range of 127/70. she was discharged home in stable condition, tolerating a regular diet and ambulating independently. medications on admission: metformin 500" actos 30 glyburide 5" zantac 150" discharge medications: 1. hydrocodone-acetaminophen 5-500 mg tablet sig: one (1) tablet po q4-6h (every 4 to 6 hours) as needed. disp:*30 tablet(s)* refills:*0* 2. ranitidine hcl 150 mg tablet sig: one (1) tablet po bid (2 times a day). 3. metoprolol tartrate 25 mg tablet sig: one (1) tablet po bid (2 times a day). disp:*60 tablet(s)* refills:*2* 4. metformin 500 mg tablet sig: one (1) tablet po bid (2 times a day). 5. pioglitazone 15 mg tablet sig: two (2) tablet po daily (daily). 6. glyburide 5 mg tablet sig: one (1) tablet po bid (2 times a day). discharge disposition: home with service facility: home care services discharge diagnosis: common bile duct injury s/p lap chole at osh dm ii htn hyperlipidemia discharge condition: stable discharge instructions: call dr. if fevers, chills, nausea, vomiting, inability to take medications, incision redness, bleeding or pus, drainage from insertion site at capped bile tube site, abdominal pain or any questions labs weekly for cbc, chem 10, ast, alt, alk phos, t.bili, albumin with results fax'd to dr. at shower no heavy lifting followup instructions: call to schedule follow up with dr. in weeks procedure: other endoscopy of small intestine other cholangiogram anastomosis of hepatic duct to gastrointestinal tract injection or infusion of oxazolidinone class of antibiotics diagnoses: unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled accidental puncture or laceration during a procedure, not elsewhere classified duodenitis, without mention of hemorrhage hypovolemia unspecified gastritis and gastroduodenitis, without mention of hemorrhage accidental cut, puncture, perforation or hemorrhage during surgical operation 

Answer: The patient is high likely exposed to